GM-CSF-dependent CD301b+ lung dendritic cells confer tolerance to inhaled allergens.
Hideki NakanoChristina WilkinsonKeiko NakanoSara A GrimmGregory WhiteheadYukitomo AraoPerry J BlackshearPeer KarmausMichael B FesslerDonald CookPublished in: Research square (2024)
The severity of allergic asthma is driven by the balance between allergen-specific T regulatory (Treg) and T helper (Th)2 cells. However, it is unclear whether specific subsets of conventional dendritic cells (cDCs) promote the differentiation of these two T cell lineaeges. We have identified a subset of lung resident type 2 cDCs (cDC2s) that display high levels of CD301b and have potent Treg-inducing activity ex vivo. Single cell RNA sequencing and adoptive transfer experiments show that during allergic sensitization, many CD301b+ cDC2s transition in a stepwise manner to CD200+ cDC2s that selectively promote Th2 differentiation. GM-CSF augments the development and maintenance of CD301b+ cDC2s in vivo, and also selectively expands Treg-inducing CD301b+ cDC2s derived from bone marrow. Upon their adoptive transfer to recipient mice, lung-derived CD301b+ cDC2s confer immunological tolerance to inhaled allergens. Thus, GM-CSF maintains lung homeostasis by increasing numbers of Treg-inducing CD301b+ cDC2s.
Keyphrases
- dendritic cells
- single cell
- cell cycle
- bone marrow
- nk cells
- immune response
- type diabetes
- metabolic syndrome
- mesenchymal stem cells
- stem cells
- cell therapy
- chronic obstructive pulmonary disease
- transcription factor
- cell proliferation
- cystic fibrosis
- adipose tissue
- induced apoptosis
- rna seq
- signaling pathway
- insulin resistance
- quality improvement